Sandra Patterson - 10 Jun 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
SVP, Controllership
Signature
/s/ Edward S. Son by Power of Attorney for Sandra C. Patterson
Issuer symbol
GILD
Transactions as of
10 Jun 2023
Transactions value $
-$11,952
Form type
4
Filing time
12 Jun 2023, 16:50:04 UTC
Previous filing
13 Mar 2023
Next filing
11 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +517 +1.97% 26.7K 10 Jun 2023 Direct F1
transaction GILD Common Stock Tax liability -$12K -153 -0.57% $78.12 26.6K 10 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -517 -2.29% 22K 10 Jun 2023 Common Stock 517 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.